| 000 | 01767 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516105901.0 | ||
| 264 | 0 | _c20130515 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1473-5571 | ||
| 024 | 7 |
_a10.1097/QAD.0b013e32835804f9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStankov, Metodi V | |
| 245 | 0 | 0 |
_aAutophagy inhibition due to thymidine analogues as novel mechanism leading to hepatocyte dysfunction and lipid accumulation. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cOct 2012 |
||
| 300 |
_a1995-2006 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 |
_aAutophagy _xdrug effects |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDNA, Mitochondrial _xdrug effects |
| 650 | 0 | 4 |
_aFatty Liver _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 |
_aHep G2 Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipid Metabolism _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicroscopy, Electron |
| 650 | 0 | 4 |
_aMitochondria, Liver _xmetabolism |
| 650 | 0 | 4 | _aNon-alcoholic Fatty Liver Disease |
| 650 | 0 | 4 |
_aStavudine _xpharmacology |
| 650 | 0 | 4 |
_aThymidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aZidovudine _xpharmacology |
| 700 | 1 | _aPanayotova-Dimitrova, Diana | |
| 700 | 1 | _aLeverkus, Martin | |
| 700 | 1 | _aVondran, Florian W R | |
| 700 | 1 | _aBauerfeind, Rudolf | |
| 700 | 1 | _aBinz, Annerose | |
| 700 | 1 | _aBehrens, Georg M N | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 26 _gno. 16 _gp. 1995-2006 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAD.0b013e32835804f9 _zAvailable from publisher's website |
| 999 |
_c22045043 _d22045043 |
||